HIV-associated skin diseases. Part II;HIV-assoziierte Hauterkrankungen. Teil II

Hautarzt

Volumn 48, Issue 1, 1997, Pages 58-72

  Plettenberg, A ^a   Ramsauer, J ^a   Meigel, W ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PITYRIASIS; PSORIASIS; REITER SYNDROME; REVIEW; SKIN TUMOR; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; SKIN DISEASE;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; DIAGNOSIS, DIFFERENTIAL; HIV INFECTIONS; HUMANS; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0030637529     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Amaral MC, Miles S, Kumar G, Nel AE (1993) Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Clin Invest 92:848-857
2. Auffret N, Quint L, Domart P, Dubertret L, Lecam JY, Binet O (1992) Pityriasis rubra pilaris in a patient with human immunodefiency virus infection. J Am Acad Dermatol 27:260-261
3. Barillan G, Gendelman R, Gallo RC, Ensoli B (1990) The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 90:7941-7945
4. Belz J, Breneman DL, Nordlund JJ, Solinger A (1989) Successfull treatment of a patient with Reiter's syndrome and acquired immunodefiency syndrome using etretinate. J Am Acad Dermatol 20:898-903
5. Beral V, Bull D, Dorby S, Weller I, Corne C, Beecham M, Jaffe HW (1992) Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 339:632-635
6. Beral V, Petermann TA, Berkelmann RL, Jaffe HW (1990) Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335:123-128
7. Casanova JM, Puig T, Rubio M (1987) Hypertrichosis of the eyelashes in acquired immunodeficiency syndrome. Arch Dermatol 123:1599-1601
8. Castanet J, Lacour JP, Bekri S, Ortonne JP (1994) Porphyria cutanae tarda in association with human immunodeficiency virus infection: Is it related to Hepatitis C infection? Arch Dermatol 130:664-665
9. Cesarman E, Chang Y, Moore PS, Jonathan WS, Knowles DM (1995) Kaposi's sarcoma-associated herpesvirus-like DNA in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186-91
10. Chang Y, Cesarman E, Pessin MS, Lee F, Culcepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869
11. Chor PJ, Santa Cruz DJ (1992) Kaposi's sarcoma. A clinicopathologic review and differential diagnosis. J Cutan Pathol 19:6-20
12. Chosidow O (1994) Drug rashes-What are the targets of cell-mediated cytotoxicity? Arch Dermatol 130:627-629
13. Cockerell CJ, Dolan E (1992) Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodefiency syndrome and renal disease. J Am Acad Dermatol 26:559-562
14. Cohen PR, Grossman ME, Silvers DN, DeLeo VA (1991) Human immunodeficiency virus-associated granuloma annulare. Int J STD AIDS 2:168-171
15. Coopman SA, Johnson RA, Platt R, Stern RS (1993) Cutaneous disease and drug reactions in HIV infection. N Engl J Med 328:1670-1674
16. Daniel CR, Norton LA, Scher RK (1992) The spectrum of nail disease in patients with human immunodeficiency infection. J Am Acad Dermatol 27:93-97
17. Don PC, Fusco F, Fried P, Batterman A, Duncanson FP, Lenox TH, Klein NC (1990) Naildyschromasia associated with zidovudine. Ann Int Med 112:145-146
18. Dover JS, Johnson RA (1991) Cutaneous manifestations of human immunodeficiency virus infection. Part II. Arch Dermatol 127 1549-1558
19. Duvic M, Crane MM, Conant M, Mahoney E, Reveille JD, Nusinoff Lehrman S (1994) Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol 130:447-451
20. Duvic M, Johnson TM, Rapini RP, Freese T, Brewton G, Rios A (1987) Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol 123:1622-1632
21. Ensoli B, Barillari G, Gallo RC (1992) Cytokines and growth factors in the pathogenesis of AlDS-associated Kaposi's sarcoma. Immunol Reviews 127:147-155
22. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Callo RC (1994) Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674-680
23. Ensoli B, Markham P, Kao V, Barillari G, Fiorelti V, Gendelman R, Raffeld M,Zon G, Callo RC (1994) Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. J Clin Invest 94:1736-1746
24. Gaddoni G, Baldassari L, Albertini F, Misciali C (1995) Melasma and acquired immunodeficiency syndrome (AIDS). J Eur Acad Dermatol Venerol 4:44-47
25. Ghigliotti G, Repetto T, Farris A, Roy MT, De Marchi R (1993) Thalidomide: Treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virus. J Am Acad Dermatol 28:271-272
26. Greenspan D, Greenspan JS (1992) Oral lesions of HIV infection: features and therapy. Aids Clin Rev 225-239
27. Gregory N (1994) Clinical manifestations of photosensitivity in patients with humán immunodeficiency virus infection. Arch Dermatol 130:630-633
28. Herndier BG, Kaplan LD, McGrath MS (1994) Pathogenesis of AIDS lymphomas. AIDS 8:1025-1049
29. Horn TD, Morison WL, Farzadegan H, Zmudzka BZ, Beer JZ (1994) Effects of psoralen plus UVA radiation (PUVA) on HIV-1 in human beings: A pilot study. J Am Acad Dermatol 31:735-740
30. Huang YQ, Buchbinder A, Li JJ, Nicolaides A, Zhang WC, Friedman-Kien AE (1992) The absence of tat sequences in tissues of HIV- negative patients with epidemic Kaposi's sarcoma. AIDS 6:1139-1142
31. Huang YQ, Li IJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D, Friedman-Kien AE (1995) Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 345:759-761
32. Itin PH, Lautenschlager S, Fluckiger R, Rufli (1993) Oral manifestations in HIV-infected patients: Diagnosis and management. J Am Acad Dermatol 29:749-760
33. Kaplan MH, Sadick NS, McNutt NS, Meltzer M, Sarngadharan MG, Pahwa S (1987) Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 16:485-506
34. Kaplan MH, Sadick NS, McNutt NS, Talmor M, Coronesi M, Hall WW (1993) Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: A new association with intravenous drug abuse. J Am Acad Dermatol 29:701-708
35. Kerschmann RL, Berger TC, Weiss LM, Herndier BG, Abrahms KM, Heon V, Schulze K, Kaplan LD, Resnik D, LeBoit PE (1995) Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Arch Dermatol. 131:1281-1288
36. Krown S, Metroka JC, Wenz (1989) Kaposi's sarcoma in the aquired immunodeficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7:1201-1207
37. LeBoit PE, Cockerell CJ (1993) Nodular lesions of erythema elevatum et diutinum in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 28:919-922
38. Manders SM, Kostman JR, Mendez L, Russin VL (1995) Thalidomide-resistent HIV-associated aphthae successfully treated with granulocyte colony-stimulating factor. J Am Acad Dermatol 33:380-382
39. Martinez-Maza O (1992) IL6 and AIDS. 46th Forum in Immunol 143:746-769
40. Maurer T, Zackheim HS, Tuffanelli L, Berger TG (1994) The use of methotrexate for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol 31.372-375
41. McNeely MC, Yarchoan R, Broder S, Lawley TJ (1989) Dermatologic complications associated with administration of 2′,3′-dideoxycytidine in patients with human immunodeficiency virus infection. J Am Acad Dermatol 21:213-217
42. Melbye M, Coté TR, Kessler L, Gail M, Biggar RJ, and the AIDS/Cancer Working Group (1994) High incidence of anal cancer among AIDS patients. Lancet 343:636-639
43. Meigel W, Ramsauer J (1994) Nichtinfektiöse Hautkrankheiten bei der HIV-Infektion. Allergol 17:327-332
44. Miettinen M, Lindenmayer AE, Chaubel A (1994) Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluations of their specifity and sensitivity in the diagnosis of vascular tumors and comparison with von Willbrand factor. Mod Pathol 7:82-90
45. Miles SA, Rezai AR, Salazar-Gonzalez JF (1990) AIDS Kaposi's sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 87:4068-4072
46. Mitchell LT, Yeager JK, Smith KJ, Skelton HG, Wagner KF, Jackson HM (1993) Cimetidine as therapy for treatment-resistent psoriasis in a patient with acquired immunodeficiency syndrome. Arch Dermatol 129:848-850
47. Mitsuyasu R (1987) Clinical variants and staging of Kaposi's sarcoma. Semin Oncol 14:13-18
48. Moore PS, Chang Y (1995) Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 332:1181-1185
49. Myskowski PL, Niedzwiecki D, Shurgot A, Kaufmann D, Krown SE, Nisce L, Safai B (1988) AIDS-associated Kaposi's sarcoma: variables associated with survival. J Am Acad Derm 6:1299-1306
50. Nakamura S, Salahuddin SZ, Biberfeld P, Ensoli B, Markham PD, Wong-Staal F, Gallo RC (1988) Kaposi's sarcoma cells: long term culture with growth factor from retrovirus infected CD4+ T cells. Science 242:426-430
51. Nandwani R, Money-Kyrle J, Hawkins DA, Staughton RCD, Philipps RH (1995) Bleomycin-induced flagellate dermatitis in AIDS patients with Kaposi's sarcoma. J Eur Acad Dermatol Venerol 4:89-93
52. Nguyen MT, Weiss PJ, Wallace MR (1995) Two-today oral desensitization to trimethoprim-sulfame-thoxazole in HIV-infected patients. AIDS 9:573-575
53. Nickoloff BJ (1991) The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on prolifterating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 127:523-529
54. Plettenberg A, Engelmann L, Meigel W (1990) Pathogenese des HIV-assoziierten Kaposi-Sarkoms - das Koebner - Phämonen als möglicher Auslösemechanismus. H+G Z f Hautkrankh 65 684-689
55. Plettenberg A, Fuzesi S, Meigel W (1990) Exazerbation einer HIV-assoziierten psoriasiformen Dermatitis unter Interferon alfa-2a-Therapie bei einem HIV-positiven Patienten mit Kaposi-Sarkom. Akt Dermatol 16:112-115
56. Plettenberg A, Gilgen K, Stoehr A, Meigel W (1991) CD4-Lymphozyten bei Erstmanifestatiopn des HIV-assoziierten Kaposi-Sarkoms. Akt Dermatol 17:276-277
57. Plettenberg A, Janik I, Kolb H, Meigel W (1991) Lokaltherapeutische Maßnahmen beim HIV-assozierten Kaposi-Sarkom mit besonderer Berücksichtigung der Röntgenweichstrahltherapie. Strahlenther Oncol 167:208-213
58. Plettenberg A, Meigel W (1993) Foscarnet-bedingte Genitalulzera. Akt Dermatol 19:355-356
59. Plettenberg A, Meigel W (1994) Das endemische Kaposi-Sarkom. Allergol 7:295-302
60. Porteus DM, Berger TG (1991) Severe cutaneous drug reactions (Steven-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection. Arch Dermatol 127:740
61. Radka SF, Nakamura S, Sakurada S, Salahuddin SZ (1993) Correlation of Oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma. J Immunol 150:5195-5201
62. Rady PL, Yen A, Rollefson JL, Orengo I, Bruce S, Hughes TK, Tyring SK (1995) Herpesvirus-like DNA sequences in non Kaposi's sarcoma skin lesions of transplant patients. Lancet 345:1339-1340
63. Robert Koch-Institut. AIDS/HIV Quartalsbericht IV/95
64. Rosenthal D, LeBoit E, Klumpp L, Berger TG (1991) Human immunodeficiency virus- associated eosinophilic folliculitis. Arch Dermatol 127:206-209
65. Salahuddin SZ, Nakamura S, Biberfeld P, Kaplan MH, Markham PD, Larsson L, Gallo RC (1988) Angiogenic properties of Kaposi's sarcoma-derived cells after long- term culture in vitro. Science 242:430-433
66. Smith KJ, Skelton HG, Drabick MJ, McCarthy WF, Ledsky R, Wagner KF (1994) Hypereosinophilia secondary to immunoodysregulation in patients with HIV-1 disease. Arch Dermatol 130:119-121
67. Smith KJ, Skelton HG, James WD, Frissman DM, Barrett TL, Angritt P, Lupton GP (1991) Papular eruption of human immunodeficiency virus disease-a review of the clinical, histologic and immunohistologic findings in 48 cases. Am J Dermatopathol 13:445-451
68. Sturzl M, Brandstetter H, Roth WK (1992) Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo. AIDS Res Hum Retrov 8:1753-1763
69. Su IJ, Hsu YS, Chang YC, Wang IW (1995) Herpesvirus-like DNA sequence in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan. Lancet 345:722-723
70. Tappero JW, Conant MA, Wolfe SF, Berger TG (1993) Kaposi's sarcoma. J Am Acad Dermatol 28:371-395
71. Taylor JF, Templeton AC, Vogel CL, Ziegler JL, Kyalwazi SK (1971) Kaposi's sarcoma in Uganda:a clinico-pathological study. Br J Cancer 8:122-135
72. Torres RA, Lin RY, Lee M, Barr MR (1992) Zidovudine-induced leukocytoclastic vasculitis. Arch Intern Med 152.850-851
73. Vogel J, Hinnchs St-H, Reynolds KR, Luciw PA, Jay G (1988) The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335.606-611
74. Wahman A, Melnik SL, Rhame FS, Potter JD (1991) The epidemiology of classic, african, and immunsuppressed Kaposi's sarcoma. Epidem Rev 13 178-199
75. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FEA, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS, Schulz TF (1995) Detection of Kaposi sarcoma associate herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346 799-802